Company intelligence / Profile preview

Biacore

Uppsala, Uppsala County, Swedencytivalifesciences.com ↗

Ownership: Private
Employees: ~300
Development stage: Commercial

Overview

Biacore developed and commercialized SPR-based biosensors that became the industry standard for label-free analysis of biomolecular interactions. The technology enables real-time measurement of binding kinetics and affinities, widely used in drug discovery and biologics development. No clinical results as it does not develop drugs.

Modalities: Device (biosensor instruments for molecular interaction analysis)
Industry: Drug Discovery Services

Partnerships

Collaborated with pharmaceutical companies and academic institutions globally for adoption of SPR technology; specific partnerships not detailed in sources.

Beyond the preview

Go deeper on Biacore.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biacore.

Explore the full profile